MP0317 + Gemcitabine + Cisplatine + Durvalumab clinical trials

MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma

This study is testing a new combination treatment for advanced bile duct cancer that can't be removed by surgery. It combines a new drug (MP0317) with standard chemotherapy and immunotherapy. Researchers want to see if this new approach helps patients live longer without their cancer growing.